Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
30.76
+0.26 (0.85%)
Mar 10, 2026, 10:55 AM CST

SHA:688319 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
-224.16362.07269.23254.37
Upgrade
Trading Asset Securities
-17.5090200
Upgrade
Cash & Short-Term Investments
217.27241.66362.07359.23454.37
Upgrade
Cash Growth
-10.09%-33.26%0.79%-20.94%298.63%
Upgrade
Accounts Receivable
-570.35491.55491.69342.52
Upgrade
Other Receivables
-11.13.781.1
Upgrade
Receivables
-571.35492.65495.48343.62
Upgrade
Inventory
-85.6872.1278.5274.5
Upgrade
Prepaid Expenses
--000.06
Upgrade
Other Current Assets
-9.454.352.662.42
Upgrade
Total Current Assets
-908.14931.19935.89874.98
Upgrade
Property, Plant & Equipment
-572.3425.87378.35259.27
Upgrade
Other Intangible Assets
-16.3316.8217.5113.78
Upgrade
Long-Term Deferred Tax Assets
-18.2114.079.567.11
Upgrade
Long-Term Deferred Charges
-291.5195.76132.3134.93
Upgrade
Other Long-Term Assets
-0.5628.895.2421.82
Upgrade
Total Assets
-1,8071,6131,4791,212
Upgrade
Accounts Payable
-86.2940.0680.6834.28
Upgrade
Accrued Expenses
-368.06346.13321.65251.98
Upgrade
Short-Term Debt
-24.224.28535
Upgrade
Current Portion of Long-Term Debt
-87.4231.6910-
Upgrade
Current Income Taxes Payable
-9.443.749.464.03
Upgrade
Current Unearned Revenue
-0.513.626.717.5
Upgrade
Other Current Liabilities
-19.6726.7911.738.88
Upgrade
Total Current Liabilities
-595.59476.22525.23341.66
Upgrade
Long-Term Debt
-249.53177.2929.99-
Upgrade
Long-Term Leases
-0.644.439.043.25
Upgrade
Long-Term Unearned Revenue
-24.7919.9820.1118.67
Upgrade
Long-Term Deferred Tax Liabilities
-2.462.722.562.3
Upgrade
Other Long-Term Liabilities
-0.531.210.091.33
Upgrade
Total Liabilities
-873.54681.84587.02367.22
Upgrade
Common Stock
-405.93406.16405.27405.27
Upgrade
Additional Paid-In Capital
-606605.75580.95570.56
Upgrade
Retained Earnings
--81.7-87.04-104.59-131.17
Upgrade
Treasury Stock
--5.56-7.96--
Upgrade
Total Common Equity
959.85924.68916.91881.63844.66
Upgrade
Minority Interest
-8.8213.8610.22-
Upgrade
Shareholders' Equity
968.34933.5930.77891.85844.66
Upgrade
Total Liabilities & Equity
-1,8071,6131,4791,212
Upgrade
Total Debt
396.68361.79237.61134.0338.25
Upgrade
Net Cash (Debt)
-179.41-120.13124.47225.2416.11
Upgrade
Net Cash Growth
---44.73%-45.88%381.08%
Upgrade
Net Cash Per Share
-0.44-0.300.310.561.08
Upgrade
Filing Date Shares Outstanding
406.36405.93406.16405.27405.27
Upgrade
Total Common Shares Outstanding
405.93405.93406.16405.27405.27
Upgrade
Working Capital
-312.55454.97410.67533.31
Upgrade
Book Value Per Share
2.362.282.262.182.08
Upgrade
Tangible Book Value
942.6908.35900.08864.11830.88
Upgrade
Tangible Book Value Per Share
2.322.242.222.132.05
Upgrade
Buildings
-224.6996.22103.17103.17
Upgrade
Machinery
-318.26299.39261.88245.29
Upgrade
Construction In Progress
-211.27181.35135.4911.63
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.